首页 > 最新文献

Palliative Medicine in Practice最新文献

英文 中文
Coping mechanism and depression among Moslem patients treated with chemotherapy 穆斯林化疗患者的应对机制与抑郁
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.5603/pmpi.2022.0014
D. Anita, Astriningrum Titipangesti, Siti Fadhillah, Wantonoro Wantonoro
Background: Chemotherapy patients commonly experience depression due to various physical complaints suffered and the length of treatment therapy. Depression is closely related to morbidity and mortality. Therefore, a good coping mechanism is needed to overcome it. This research aims to determine the relationship between coping mechanisms and depression in chemotherapy patients. Patients and methods: The design used was a quantitative correlation with a cross-sectional approach. The respondents recruited were 52 patients using an accidental sampling technique. The research instrument used was a questionnaire. Data were analysed using the contingency coefficient test. Results: The results showed that most respondents had maladaptive coping mechanisms (53.2%), experienced depression (59.6%), and there was no relationship between coping mechanisms and depression (p = 0.213). Conclusions: many factors can influence the depression level of cancer patients. These factors contribute together, but some of them do not directly contribute to depression. One of the factors that do not directly contribute is the coping mechanism.
背景:化疗患者常因各种生理疾患和治疗时间的长短而出现抑郁。抑郁症与发病率和死亡率密切相关。因此,需要一个良好的应对机制来克服它。本研究旨在探讨化疗患者应对机制与抑郁的关系。患者和方法:采用的设计是定量相关的横断面方法。采用随机抽样技术招募了52名患者作为调查对象。使用的研究工具是问卷调查。采用偶然性系数检验对数据进行分析。结果:调查结果显示,大多数被调查者存在不适应的应对机制(53.2%),有抑郁经历(59.6%),应对机制与抑郁无相关性(p = 0.213)。结论:影响肿瘤患者抑郁水平的因素很多。这些因素共同作用,但其中一些并不直接导致抑郁症。其中一个不直接起作用的因素是应对机制。
{"title":"Coping mechanism and depression among Moslem patients treated with chemotherapy","authors":"D. Anita, Astriningrum Titipangesti, Siti Fadhillah, Wantonoro Wantonoro","doi":"10.5603/pmpi.2022.0014","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0014","url":null,"abstract":"Background: Chemotherapy patients commonly experience depression due to various physical complaints suffered and the length of treatment therapy. Depression is closely related to morbidity and mortality. Therefore, a good coping mechanism is needed to overcome it. This research aims to determine the relationship between coping mechanisms and depression in chemotherapy patients. Patients and methods: The design used was a quantitative correlation with a cross-sectional approach. The respondents recruited were 52 patients using an accidental sampling technique. The research instrument used was a questionnaire. Data were analysed using the contingency coefficient test. Results: The results showed that most respondents had maladaptive coping mechanisms (53.2%), experienced depression (59.6%), and there was no relationship between coping mechanisms and depression (p = 0.213). Conclusions: many factors can influence the depression level of cancer patients. These factors contribute together, but some of them do not directly contribute to depression. One of the factors that do not directly contribute is the coping mechanism.","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48520633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of opioid analgesics in chronic kidney disease 阿片类镇痛药在慢性肾病中的应用
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.5603/pmpi.2022.0010
A. Sołtysik, M. Graczyk, J. Woroń
{"title":"Use of opioid analgesics in chronic kidney disease","authors":"A. Sołtysik, M. Graczyk, J. Woroń","doi":"10.5603/pmpi.2022.0010","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0010","url":null,"abstract":"","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46326620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Palliative care — looking at new directions 姑息治疗——寻找新的方向
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.5603/pmpi.2022.0025
W. Leppert
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. Wojciech Leppert 2 Chair of Palliative Medicine, Institute of Medical Sciences Collegium Medicum University of Zielona Góra, Poland University Hospital of Heliodor Święcicki, Partner of Poznań University of Medical Sciences, Poland
这篇文章是根据创造性共同归因非商业无衍生工具4.0国际(CC BY-NC-ND 4.0)许可证开放获取的,允许下载文章并与他人分享,只要他们信任作者和出版商,但不允许以任何方式更改或商业使用。Wojciech Leppert 2 Zielona Góra大学医学院医学科学研究所姑息医学主任,波兰波兹南医学科学大学合作伙伴,波兰赫利奥多尔大学医院
{"title":"Palliative care — looking at new directions","authors":"W. Leppert","doi":"10.5603/pmpi.2022.0025","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0025","url":null,"abstract":"This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. Wojciech Leppert 2 Chair of Palliative Medicine, Institute of Medical Sciences Collegium Medicum University of Zielona Góra, Poland University Hospital of Heliodor Święcicki, Partner of Poznań University of Medical Sciences, Poland","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48676860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten reasons to consider cannabinoids in everyday clinical practice 在日常临床实践中考虑使用大麻素的十个理由
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.5603/pmpi.2022.0013
A. Lewandowska, M. Graczyk
Medical cannabis is attracting more and more interest among both patients and healthcare professionals. Despite the long history of using this plant for medicinal purposes, the current approach to medicine, which is primarily based on facts, forces us to take a scientific approach in the selection of products and substances from the cannabinoid group. More and more scientific and clinical studies are providing evidence of their effectiveness. Clinical trials with small groups of patients as well as case reports show the benefits of medical cannabis, while larger trials often do not confirm clear improvement compared to other available treatments. Both physicians and their patients need to know in which indications clinical benefits are possible and whether the proposed therapy is safe. Only after analysing the patient’s history, interviewing and examining, in a highly individualized and detailed manner (including relative and absolute contraindications) can cannabinoid therapy be considered. They are more often used as an addition to basic and standard therapy, which can improve its effectiveness. Less frequently we choose cannabinoids as drugs of the first choice used in monotherapy. The article aims to present 10 reasons why cannabinoids are worth considering for use in everyday clinical practice and to prepare practitioners to answer the questions most asked by patients
医用大麻正在吸引越来越多的患者和医疗保健专业人员的兴趣。尽管这种植物的药用历史悠久,但目前的医学方法主要基于事实,迫使我们在选择大麻素组的产品和物质时采取科学的方法。越来越多的科学和临床研究为其有效性提供了证据。对一小群患者进行的临床试验以及病例报告显示了医用大麻的益处,而与其他现有治疗方法相比,更大规模的试验往往没有证实明显的改善。医生和他们的病人都需要知道哪些适应症和临床益处是可能的,以及所建议的治疗是否安全。只有在以高度个性化和详细的方式(包括相对和绝对禁忌症)分析患者的病史,访谈和检查之后,才能考虑大麻素治疗。它们更常被用作基础和标准治疗的补充,可以提高其有效性。我们很少选择大麻素作为单一疗法的首选药物。本文旨在提出大麻素在日常临床实践中值得考虑使用的10个原因,并准备从业者回答患者最常问的问题
{"title":"Ten reasons to consider cannabinoids in everyday clinical practice","authors":"A. Lewandowska, M. Graczyk","doi":"10.5603/pmpi.2022.0013","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0013","url":null,"abstract":"Medical cannabis is attracting more and more interest among both patients and healthcare professionals. Despite the long history of using this plant for medicinal purposes, the current approach to medicine, which is primarily based on facts, forces us to take a scientific approach in the selection of products and substances from the cannabinoid group. More and more scientific and clinical studies are providing evidence of their effectiveness. Clinical trials with small groups of patients as well as case reports show the benefits of medical cannabis, while larger trials often do not confirm clear improvement compared to other available treatments. Both physicians and their patients need to know in which indications clinical benefits are possible and whether the proposed therapy is safe. Only after analysing the patient’s history, interviewing and examining, in a highly individualized and detailed manner (including relative and absolute contraindications) can cannabinoid therapy be considered. They are more often used as an addition to basic and standard therapy, which can improve its effectiveness. Less frequently we choose cannabinoids as drugs of the first choice used in monotherapy. The article aims to present 10 reasons why cannabinoids are worth considering for use in everyday clinical practice and to prepare practitioners to answer the questions most asked by patients","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48811148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in prevention and treatment of post-radiotherapy xerostomia in patients with head and neck cancer 头颈癌放疗后口干症的防治进展
Q4 Medicine Pub Date : 2022-09-29 DOI: 10.5603/pmpi.a2022.0026
Z. Żylicz, Agnieszka Solarska
{"title":"Recent advances in prevention and treatment of post-radiotherapy xerostomia in patients with head and neck cancer","authors":"Z. Żylicz, Agnieszka Solarska","doi":"10.5603/pmpi.a2022.0026","DOIUrl":"https://doi.org/10.5603/pmpi.a2022.0026","url":null,"abstract":"","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42292643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of pain management nursing care program for children with cancer 癌症儿童疼痛管理护理方案的制定
Q4 Medicine Pub Date : 2022-09-15 DOI: 10.5603/pmpi.a2022.0024
N. Naseri, A. Irajpour, Atefeh Shamsi
{"title":"Development of pain management nursing care program for children with cancer","authors":"N. Naseri, A. Irajpour, Atefeh Shamsi","doi":"10.5603/pmpi.a2022.0024","DOIUrl":"https://doi.org/10.5603/pmpi.a2022.0024","url":null,"abstract":"","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43805973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of opioid analgesics in palliative care in Ukraine: Changes in legislation and availability 阿片类镇痛药在乌克兰姑息治疗中的使用:立法和可得性的变化
Q4 Medicine Pub Date : 2022-06-02 DOI: 10.5603/pmpi.2022.0004
S. Shunkina, Iryna Chukhray
Introduction: The main task of palliative care is to improve the quality of life of a patient, and the therapy of chronic pain with opioids is a significant problem for palliative care patients in Ukraine. Therefore, this study aimed to assess the opioid availability for palliative care patients in Ukraine. Methods: Analysis of the list and consumption of opioids according to the scientific publications and legal documents. Results: It was found that in Ukraine as of June 2021, 12 international non-proprietary names of opioids were registered, most of which are represented by several dosage forms, which makes it possible for patients to receive adequate pain relief through non–invasive therapy with oral forms. It was shown that two thirds (63.2%) of trade names of opioids registered in Ukraine were of domestic origin. Based on a comparative analysis of the range of opioids, available in current regulatory documents, it was established that in the State Register of Medicines of Ukraine and the Unified clinical protocol there is an almost identical list of opioids (12 drugs). However, in the State Drug Formulary and the National List of Essential Medicines, this list is much smaller (8 and 5 drugs, respectively). Since 2013 changes in the regulatory documents on the medical use of opioids in Ukraine have occurred, and oral morphine was registered for the first time, allowing access to adequate pain relief. Analysis of the morphine con sumption level by dosage forms has shown that before 2013, the pharmacies sold only morphine in injections, and since 2013, the consumption of oral morphine increased. Conclusions. Changes in regulatory documents partially simplified the complicated process of obtaining opioids by patients. However, more than 80% of patients still do not receive adequate pain therapy due to the hesitancy of doctors to prescribe opioids and an extremely insufficient number of pharmacies (1.8%) that sell opioids for the population.
引言:姑息治疗的主要任务是提高患者的生活质量,阿片类药物治疗慢性疼痛是乌克兰姑息治疗患者的一个重大问题。因此,本研究旨在评估乌克兰姑息治疗患者的阿片类药物可用性。方法:根据科学出版物和法律文件对阿片类药物的清单和消费情况进行分析。结果:研究发现,截至2021年6月,乌克兰共注册了12个阿片类药物的国际非专利名称,其中大多数由几种剂型代表,这使得患者可以通过口服形式的非侵入性治疗获得足够的疼痛缓解。研究表明,在乌克兰注册的阿片类药物商品名中,有三分之二(63.2%)源自国内。根据现有监管文件中对阿片类药物范围的比较分析,确定乌克兰国家药品登记册和统一临床方案中有一份几乎相同的阿片类物质清单(12种药物)。然而,在《国家药品目录》和《国家基本药物清单》中,这一清单要小得多(分别为8种和5种药物)。自2013年以来,乌克兰关于阿片类药物医疗用途的监管文件发生了变化,首次注册了口服吗啡,使其能够获得充分的疼痛缓解。按剂型对吗啡消费水平的分析表明,2013年之前,药店只销售注射用吗啡,自2013年以来,口服吗啡的消费量有所增加。结论。监管文件的变化部分简化了患者获得阿片类药物的复杂过程。然而,超过80%的患者仍然没有得到足够的疼痛治疗,因为医生对开阿片类药物犹豫不决,而且为人群销售阿片类药品的药店数量极为不足(1.8%)。
{"title":"The use of opioid analgesics in palliative care in Ukraine: Changes in legislation and availability","authors":"S. Shunkina, Iryna Chukhray","doi":"10.5603/pmpi.2022.0004","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0004","url":null,"abstract":"Introduction: The main task of palliative care is to improve the quality of life of a patient, and the therapy of chronic pain with opioids is a significant problem for palliative care patients in Ukraine. Therefore, this study aimed to assess the opioid availability for palliative care patients in Ukraine. Methods: Analysis of the list and consumption of opioids according to the scientific publications and legal documents. Results: It was found that in Ukraine as of June 2021, 12 international non-proprietary names of opioids were registered, most of which are represented by several dosage forms, which makes it possible for patients to receive adequate pain relief through non–invasive therapy with oral forms. It was shown that two thirds (63.2%) of trade names of opioids registered in Ukraine were of domestic origin. Based on a comparative analysis of the range of opioids, available in current regulatory documents, it was established that in the State Register of Medicines of Ukraine and the Unified clinical protocol there is an almost identical list of opioids (12 drugs). However, in the State Drug Formulary and the National List of Essential Medicines, this list is much smaller (8 and 5 drugs, respectively). Since 2013 changes in the regulatory documents on the medical use of opioids in Ukraine have occurred, and oral morphine was registered for the first time, allowing access to adequate pain relief. Analysis of the morphine con sumption level by dosage forms has shown that before 2013, the pharmacies sold only morphine in injections, and since 2013, the consumption of oral morphine increased. Conclusions. Changes in regulatory documents partially simplified the complicated process of obtaining opioids by patients. However, more than 80% of patients still do not receive adequate pain therapy due to the hesitancy of doctors to prescribe opioids and an extremely insufficient number of pharmacies (1.8%) that sell opioids for the population.","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45313385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Palliative sedation at home: A medical act practicable everywhere 家庭缓和镇静:一种在任何地方都可行的医疗行为
Q4 Medicine Pub Date : 2022-06-02 DOI: 10.5603/pmpi.2022.0001
G. Armento, A. Parisi, G. Ravoni, G. Spinelli, V. Cofini, S. Necozione, L. Verna, G. Porzio
{"title":"Palliative sedation at home: A medical act practicable everywhere","authors":"G. Armento, A. Parisi, G. Ravoni, G. Spinelli, V. Cofini, S. Necozione, L. Verna, G. Porzio","doi":"10.5603/pmpi.2022.0001","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0001","url":null,"abstract":"","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47456882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Palliative care — moving forward 姑息治疗——向前迈进
Q4 Medicine Pub Date : 2022-06-02 DOI: 10.5603/pmpi.2022.0009
W. Leppert
{"title":"Palliative care — moving forward","authors":"W. Leppert","doi":"10.5603/pmpi.2022.0009","DOIUrl":"https://doi.org/10.5603/pmpi.2022.0009","url":null,"abstract":"","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46887644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and multidimensional deprivation in rural women with cancer in Iran 新冠肺炎与伊朗癌症农村妇女的多层面剥夺
Q4 Medicine Pub Date : 2022-06-02 DOI: 10.5603/PMPI.2021.0032
Mozhgan Moshtagh
{"title":"COVID-19 and multidimensional deprivation in rural women with cancer in Iran","authors":"Mozhgan Moshtagh","doi":"10.5603/PMPI.2021.0032","DOIUrl":"https://doi.org/10.5603/PMPI.2021.0032","url":null,"abstract":"","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48434249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Palliative Medicine in Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1